Table 11.

Sample Emergency Management Protocol for Individuals with MADD

Patient
identification
details
Name: _____________________________________________________
Date of birth: ________________________________________________
Medical record number: _______________________________________
Diagnosis This individual has been diagnosed with multiple acyl-CoA dehydrogenase deficiency (MADD). MADD is an inherited disorder of fatty acid and amino acid metabolism.
Warning signs/
symptoms
Intercurrent infections, poor oral intake, vomiting, or diarrhea can precipitate metabolic decompensation leading to vomiting, lethargy, metabolic acidosis, lactic acidosis, and coma. Prompt provision of adequate calories (reversal of catabolism) and intravenous fluids are essential. If not adequately treated, patients can develop severe hypoglycemia, liver failure, muscle breakdown, kidney failure, and permanent neurologic damage. Severe morbidity and even death can occur.
Emergency room
management
  • Start intravenous fluid immediately even if not clinically dehydrated with 10% dextrose and appropriate electrolytes at 1.5 times maintenance rate. It is imperative to prevent or reverse catabolism immediately.
  • Correct metabolic acidosis by giving sodium bicarbonate if acidosis is severe (pH <7.10 or bicarbonate <10 mEq/L).
  • Do not wait for results of laboratory evaluation before starting intravenous fluids with glucose.
  • Monitor blood glucose levels every 1-2 hours initially and maintain glucose levels above 100 mg/dL.
Laboratory
evaluation
Urgent labs:
  • STAT blood gas (arterial or venous), ammonia, and lactic acid
  • Glucose, liver transaminases (AST, ALT)
  • Electrolytes with bicarbonate, blood urea nitrogen (BUN), creatinine
  • Creatine kinase (CK)
  • Complete blood counts (CBC) with differential and additional evaluation when infection is suspected.
Additional labs to be sent if feasible:
  • Plasma free and total carnitine, plasma acylcarnitine profile, urine organic acids
Metabolic center
contact
Emergency contact phone or pager of the patient's metabolic center should be provided here. Stabilization of the patient should be the first priority.

From: Multiple Acyl-CoA Dehydrogenase Deficiency

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.